0 items USD 0.00Search
Your search for "mrrpb5 global malignant glioma market size status forecast 2019 2025" gave back 1540521 results.
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors,...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Recurrent Malignant Glioma - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Summary Publisher estimates that the Malignant Glioma Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025,...
Catalog:
HYR
May 2021
Price: USD 2,000.00
Summary The Malignant Glioma Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Recurrent Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
Catalog:
Global Markets Direct
December 2022
Price: USD 2,000.00
Malignant glioma, a tumor derived from the nerve epithelium, is generally referred to as glioma, accounting for 40-50% of brain tumors, and is the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Recurrent Malignant Glioma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2021
Price: USD 2,000.00
Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Malignant glioma's are one of the common sub-type of primary brain tumors which are highly invasive, aggressive and neurologically destructive...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Recurrent Malignant Glioma - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
June 2020
Price: USD 2,000.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
